Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Breast Cancer
•
Radiation Oncology
•
General Radiation Oncology
•
COVID-19
Are you altering your use of Active Breathing Coordination for breath hold technique patients in light of the COVID-19 pandemic?
Answer from: Radiation Oncologist at Community Practice
We use DIBH, and this has not changed anything in our practice.
Sign in or Register to read more
7092
Related Questions
Is keratosis follicularis (Darier disease) a contraindication to receipt of PMRT?
With the presentation of HypoG-01 phase III UNICANCER trial at ESMO 2024, should hypofractionated radiotherapy be the standard across the board for breast cancer?
Is 5fx APBI and no endocrine therapy a new standard of care for women over 70 years old with low-risk breast cancer given the interim analysis of the EUROPA trial?
Would you ever considering de-escalating therapy in any way for women with inflammatory breast cancer who had a complete pathologic response after surgery?
Would you hold CGRP (calcitonin gene-related peptide) monoclonal antibodies such as Eptinezumab-jjmr (Vyepti) before, during, or after lung SBRT?
How do you choose between ALND and RNI in the setting of LYMPHA or S-Lympha surgery?
Do you hold endocrine therapy during adjuvant breast radiotherapy?
Do patients with homocystinuria have an increase risk of radiation toxicity?
Do young, early-stage breast cancer patients with pCR to chemoimmunotherapy still benefit from PMRT?
Should PMRT be offered for ypN0(i+) disease if only 1-2 nodes were removed in the post-chemotherapy SLNB and there is no plan for a completion AxLND?